Sumitomo Pharma , Ltd. Profit Margin

Sumitomo Pharma , Ltd. (SMDPY) currently reports a profit margin of 23.77% as of June 2026. That compares with 4.54% in the prior-year period — up 423.3% year over year. That is above the sector sector average of 13.16%. Use the charts on this page to explore Sumitomo Pharma , Ltd.'s profit margin history and peer comparisons.

Sumitomo Pharma , Ltd.'s profit margin increased from 4.54% to 23.77% — a 423.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sumitomo Pharma , Ltd.'s profit margin of 23.77% is higher than the its sector sector average of 13.16%. That is roughly 80.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Sumitomo Pharma , Ltd.'s current 23.77% should be judged against industry norms (sector average: 13.16%) and against SMDPY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 23.77%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Sumitomo Pharma , Ltd., and consider following SMDPY for alerts when major investors trade the stock.